This module will discuss intraoperative & postoperative considerations for refractive cataract surgery.
This activity is supported by independent educational grants from Alcon and Johnson & Johnson Vision.
This module will discuss intraoperative & postoperative considerations for refractive cataract surgery.
This activity is supported by independent educational grants from Alcon and Johnson & Johnson Vision.
Upon completion of this activity, the participant should be able to:
In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+

Francis Mah, MD
Director of Corneal and External Disease
Co-Director of Refractive Surgery
Scripps Clinic
La Jolla, CA

Dagny Zhu, MD
Cornea, Cataract & Refractive Surgeon
Medical Director & Owner, NVISION Eye Centers
Rowland Heights, CA
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Francis Mah, MD, has had a financial agreement or affiliation during the past year with the following ineligible companies in the form of Consultant: Alcon, Allergan/AbbVie, Dompé, Johnson & Johnson Vision, Kiova, Novartis, Santen, and Sun Pharmaceutical Industries. Speaker’s Bureau: Dompé, Johnson & Johnson Vision, Santen, Sun Pharmaceutical Industries, and Tarsus Pharmaceuticals.
Dagny Zhu, MD, has had a financial agreement or affiliation during the past year with the following ineligible companies in the form of Consultant: Alchemy Vision, Alcon, Allergan/AbbVie, Bausch + Lomb, Bruder, Bryn Mawr Communications, Entelexo, Eyesafe, Eyenovia, IrisVision, Johnson & Johnson, Lensar, Ocuphire, Sight Sciences, Tarsus Pharmaceuticals, and Visus Therapeutics. Grant/Research Support: Alcon and Lensar. Speaker's Bureau: Allergan/AbbVie and Santen. Stock/Shareholder: Glaukos.
The Evolve staff and planners have no financial relationships with ineligible companies.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Alcon, or Johnson & Johnson Vision.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Release Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!